EVER Pharma
Magdalena Schmitzberger is an experienced portfolio manager at EVER Neuro Pharma since November 2020, following a role as a business analyst at Lifescience Dynamics Limited from October 2019 to October 2020, where work included responsibilities as a junior business analyst. Prior to this, Magdalena undertook a research project at the Blizard Institute from July 2017 to October 2017. Magdalena holds a Master of Science in Drug Discovery and Pharma Management from UCL (2018-2019) and a Bachelor of Science in Neuroscience from Queen Mary University of London (2015-2018), along with a Matura and Carpentry Engineer degree from Gymnasium Werkschulheim Felbertal (2006-2015).
This person is not in any offices
EVER Pharma
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics. From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety. Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules. We market our products in more than 70 countries around the world through our own international affiliates and strategic partners.